<DOC>
<DOCNO>
EP-0000520
</DOCNO>
<TEXT>
<DATE>
19790207
</DATE>
<IPC-CLASSIFICATIONS>
A61K-38/21 C07K-14/555 <main>C12P-21/00</main> C07K-14/435 C12P-21/00 A61K-45/02 
</IPC-CLASSIFICATIONS>
<TITLE>
improvement in or relating to a process for producing interferon.
</TITLE>
<APPLICANT>
wellcome foundgb<sep>the wellcome foundation limited<sep>the wellcome foundation limitedunicorn house 160 euston road p.o. box 129london nw1 2bpgb<sep>the wellcome foundation limited<sep>
</APPLICANT>
<INVENTOR>
johnston michael denis<sep>johnston, michael denis<sep>johnston, michael denis16 altyre waybeckenham kentgb<sep>johnston, michael denis  <sep>johnston, michael denis16 altyre waybeckenham kentgb<sep>
</INVENTOR>
<ABSTRACT>
that proteinaceous substance interferon, which has  antiviral properties and may also be used in the treatment of  cancer, is produced by many types of cell cultures after the  addition of an inducer, such as a virus.  the amounts of interferon  produced in this way can however, vary considerably.  the  cells from which interferon is produced may be stimulated  into producing in this way can however, vary considerably.  the  incubating the cells, prior to induction, in a medium containing  an effective non-toxic amount of a straight chain, saturated  carboxylic acid or a salt thereof.  
</ABSTRACT>
</TEXT>
</DOC>
